Latest press releases
Spending on internal R&D activities in Biotechnology increased by 13.0% in 2022, reaching 2,565 million euros. The full-time equivalent staff dedicated to internal R&D activities in biotechnology was 35,301.2. 58.0% were women.
Previous press releases| Indicator | Note | Value | Variation |
|---|---|---|---|
| Internal expenditure | 1 | 2,565,367 | 13.0 |
| Employed personnel Total | 2 | 35,301.2 | 7.3 |
| Employed personnel Women | 2 | 20,474.8 | 8.0 |
| Researchers. Total | 2 | 22,324.6 | 6.6 |
| Researchers. Women | 2 | 12,176.5 | 7.4 |
|
|||
Most popular tables
-
- Last modified:
- 04/09/2024
- File size:
- 1,861.00 bytes
- Variables:
- Years, Origin of funds/unit
-
- Last modified:
- 17/04/2024
- File size:
- 1,532.00 bytes
- Variables:
- Execution sector, Origin of funds
-
- Last modified:
- 05/08/2024
- File size:
- 2,126.00 bytes
- Variables:
- Branch of activity served, Indicator type
-
- Last modified:
- 15/11/2024
- File size:
- 4,507.00 bytes
- Variables:
- Autonomous Communities and Cities, Indicator type
Did you know...?
The objective of the Statistics on Biotechnology Use is the measurement of the national effort in biotechnology-related activities, so that it is capable of providing the necessary information for the taking of adequate scientific-technological policy decisions. In this regard, the objective is to ascertain the type of biotechnology-related activities that are carried out in each of the sectors in which the economy is divided; the final application areas of the products obtained via the development of biotechnologies; economic and human resources appointed to the biotechnology-related productive and investigation activity in Spain.
Since the 2021 edition of the Statistics on the use of Biotechnology, the statistical unit has been modified in the Business Sector due to the coordination of this operation with the Statistics on R&D activities. The statistical unit is the Statistical Company as defined in European Regulation 696/1993.